Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Camdiab, Ypsomed.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Nanjing Leads, Sanofi, Regeneron.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Bayer, Hyperfine, Zeta Surgical.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Ionis, Insignis, Neuropace, Organon.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Caris.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Alvotech, Disc, Electra, Huidagene, Journey Medical.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Aitrics, Biotia, Lumithera, Simbiosys.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Bioarctic, Feliqs, Nehlius Biotech, Jenscare, Remegen.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Bioarctic, Eli Lilly, Feliqs, Lexicon, Verastem.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Neuraxis, Qiagen, Quanta.